According to a report by the National Cancer Institute in July 2021, 1 in 100 newly diagnosed diabetic patients is diagnosed with pancreatic cancer within three years. This finding has been supported by large-scale sample studies published in several medical journals, highlighting the necessity for close monitoring of pancreatic cancer in diabetic patients after diagnosis.
In 2021, the number of newly diagnosed diabetes cases in the United States reached 1.2 million. Meanwhile, according to the Taiwan Diabetes Yearbook, Taiwan reports approximately 160,000 new diabetes cases each year.
For newly diagnosed diabetic patients, the need for pancreatic cancer blood testing within three years is particularly urgent to detect and treat potential pancreatic cancer as early as possible.